Melphalan 50mg Injection

Melphalan 50mg is an injectable alkylating chemotherapy used in multiple myeloma and selected other cancer regimens. High-dose treatment may form part of preparation for an autologous stem-cell transplant.
The freshly prepared medicine is given by intravenous infusion using the regimen-specific dose and timing. The solution is used promptly because its stability after preparation is limited.
Melphalan forms cross-links between DNA strands, preventing replication and causing death of susceptible tumour cells.
Low blood counts, mouth and gut inflammation, nausea, diarrhoea and hair loss can occur. Severe infection and organ toxicity are important risks, especially with high doses.
Kidney function, blood counts and the transplant plan affect treatment. Marrow suppression can be prolonged and may require transfusion and infection support.
Can substantially reduce myeloma-cell burden, including before stem-cell rescue in suitable patients.
The collected cells can restore blood-cell production after the high-dose treatment suppresses the marrow.
No. Oral and intravenous regimens have different exposure and treatment contexts.
Inflammation and ulceration can interfere with eating and increase infection risk during low blood counts.
Melphalan loses stability after reconstitution and dilution, so preparation and administration are closely coordinated.
Alkylating agent: a medicine that chemically damages DNA. Autologous transplant: return of a patient’s own previously collected stem cells. Conditioning: treatment before a stem-cell transplant.; AR: Melphalan 50mg حقن; FR: Melphalan 50mg injection; PT: Melphalan 50mg injeção; ES: Melphalan 50mg inyección; RU: Melphalan 50mg инъекция; ID: Melphalan 50mg suntikan; VI: Melphalan 50mg thuốc tiêm; MS: Melphalan 50mg suntikan; TL: Melphalan 50mg iniksyon; ZH-SG: Melphalan 50mg 注射剂
International B2B Enquiry
Send a structured B2B enquiry for Melphalan 50mg Injection under Oncology Care. Global Medicines Export helps international buyers review product information, pack details, quantity requirements, destination-market needs, quotation support and export documentation coordination from India.
Product name, required strength or pack, expected quantity, destination country, buyer type and preferred manufacturer if any.
Availability, quotation support, documentation expectations and shipment-ready order communication can be reviewed before confirmation.
Commercial invoice, packing information, manufacturer details, batch details and supporting documents where applicable and available.
Product availability, quotation, and documentation support are coordinated for international B2B enquiries.
Melphalan 50mg Injection